av/alembic--big.svg

COM:ALEMBICPHARMACEUTICALS

Alembic Pharmaceuticals

  • Stock

Last Close

1,040.35

21/11 09:59

Market Cap

196.41B

Beta: -

Volume Today

54.80K

Avg: -

Company Information

msh idCOM:ALEMBICPHARMACEUTICALS
symbolAPLLTD
nameAlembic Pharmaceuticals Limited
homepage urlhttps://alembicpharmaceuticals.com
countryIN
sectorHealthcare
industryDrug Manufacturers - Specialty & Generic
marketSTOCKS
employee count14.86K
crunchbase url-
linkedin url-
founders-

Market Metrics

market cap2.34B
enterprise value-
stage-
raised capital-
valuation-

Web & Growth Metrics

monthly webtraffic-
monthly webtraffic growth-
growth score 14-
growth score 28-
growth score 90-
growth score 365-

LTM & NTM Metrics

revenue ltm-
gross profit ltm-
ebitda ltm-
net income ltm-
revenue ntm-
gross profit ntm-
ebitda ntm-
net income ntm-

Growth & Performance Metrics

growth cost and expenses0.13
growth cost of revenue-0.01
growth depreciation and amortization-0.04
growth ebitda-0.27
growth ebitda ratio-0.32
growth eps-
growth eps diluted-
growth general and administrative expenses0.14
growth gross profit0.12
growth gross profit ratio0.04

Operating Metrics

cost and expenses555.6M
cost of revenue555.6M
depreciation and amortization34.35M
ebitda110.84M
ebitda ratio0.18
eps0.32
eps diluted0.32
operating expenses349.22M
operating income76.5M
operating income ratio0.12

Balance Sheet Metrics

accounts receivables-26.69M
capital expenditure-53.1M
cash at beginning of period7.32M
cash at end of period9.04M
inventory192.78M
working capital ttm13.24B

Financial Metrics (2022-2026)

20222023202420252026
Revenue Metrics
Revenue-----
Revenue Growth-----
Revenue Multiple-----
Profit Metrics
Gross Profit-----
Gross Profit Growth-----
Gross Profit Multiple-----
EBITDA Metrics
EBITDA-----
EBITDA Growth-----
EBITDA Multiple-----
Net Income Metrics
Net Income-----
Net Income Growth-----
Net Income Multiple-----